Cirrose hepática – abordagem diagnóstica e terapêutica
Palavras-chave:
cirrose hepática, hipertensão portal, hepatites virais, hepatopatia crônicaResumo
As hepatopatias crônicas são importantes causas de morbimortalidade em todo o mundo. Admite-se que existam mais de 70 milhões de indivíduos infectados pelo vírus da hepatite C (HCV) e mais de 350 milhões de infectados pelo vírus da hepatite B (HBV), distribuídos pelos cinco continentes. Essas duas enfermidades podem se cronificar e complicar, ocasionando o surgimento de cirroses e de carcinoma hepatocelular. O consumo e uso abusivo de álcool e a doença hepática gordurosa não alcoólica continuam sendo outras importantes causas de cirrose hepática, rivalizando-se com as hepatites virais, como as maiores etiologias da cirrose hepática. Nesse artigo abordaremos os principais fatores etiológicos, manifestações clínicas e abordagem diagnóstica e terapêutica.
Referências
Pawlotsky JM. Clinical virology of Hepatitis C. In: MARCELLIN, P. (Editor). Management of Patients with Viral Hepatitis. Paris, 2004.
Zoulim F. Clinical virology of Hepatitis B. In: MARCELLIN, P. (Editor). Management of Patients with Viral Hepatitis. Paris, 2004.
DiBisceglie AM & Hoofnagle JH. Management of Chronic Viral Hepatitis. In: BACON, B. & Di BISCEGLIE, A.M. (Editors). Liver Disease: Diagnosis and Management. Churchill Livingstone, Philadelphia, Estados Unidos, 2000, pag.98- 106.
Hadzyiannis S. Viral Hepatitis: Clinical Features. In: BACON, B. & Di BISCEGLIE, A.M. (Editors). Liver Disease: Diagnosis and Management. Churchill Livingstone, Philadelphia, Estados Unidos, 2000, pag. 79-97.
Manns MP. Autoimmune Hepatitis. In: BACON, B. & Di BISCEGLIE, A.M. (Editors). Liver Disease: Diagnosis and Management. Churchill Livingstone, Philadelphia, Estados Unidos, 2000, pag. 107-118.
R. Schwarzer, D. Kivaranovic, R. Paternostro, M. Mandorfer et al. Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose- response study. Aliment Pharmacol Ther. 2018;1–8.
Lourdes Cabrera, Puneeta Tandon & Juan G. Abraldes. An update on the management of acute esophageal variceal bleeding. Gastroenterología y Hepatología. Gastroenterol Hepatol. 2016.
R. DE FRANCHIS. Review article: definition and diagnosis in portal hypertension – a continued problems with the Baveno consensus? Aliment Pharmacol Ther 2004;20 (Suppl. 3): 2–6.
Salvador Augustin, Monica Pons, James B. Maurice, Christophe Bureau et al.: Expanding the Baveno VI Criteria for the Screening of Varices in Patients With Compensated Advanced Chronic Liver Disease. Hepatology, vol. 66, no. 6, 2017.
Roberto de Franchis, on behalf of the Baveno VI Faculty. Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.Journal of Hepatology 2015 vol. 63 j 743–752.
Hugo Perazzo, Flavia Fernandes, Elio Castro Filho, Renata M Perez. Points to be considered when using transient elastography for diagnosis of portal hypertension according to the Bavenoʼs VI consensus. Journal of Hepatology. June 2015 S0168-8278(15)00468-7 DOI: doi.org/10.1016/j.jhep.2015.06.036.
Guadalupe Garcia-Tsao & Jaime Bosch: Varices and Variceal Hemorrhage in Cirrhosis. A new view of an old problem. Clin Gastroenterol Hepatol. 2015 November ; 13(12): 2109–2117. doi:10.1016/j.cgh.2015.07.012.
Elba Llop, Marta Lopez, Juan de la Revilla, Natalia Fernandez, et al. Validation of non invasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease. doi: 10.1111/jgh.13781.
Maxime Mallet, Marika Rudler, Dominique Thabut. Variceal bleeding in cirrhotic patients. Gastroenterology Report, 5(3), 2017, 185–192.
Rafael Paternostro, Thomas Reiberger, Theresa Bucsics. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease. World J Gastroenterol 2019 January 21; 25(3): 308-329.
